Shares of Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) hit a new 52-week high during trading on Monday. The company traded as high as $74.47 and last traded at $74.1050, with a volume of 11,246 shares trading hands. The stock had previously closed at $72.76.
Lonza Group Stock Up 2.6%
The company has a current ratio of 1.66, a quick ratio of 1.21 and a debt-to-equity ratio of 0.42. The firm’s 50-day moving average price is $69.75 and its 200 day moving average price is $66.99.
Lonza Group Company Profile
Lonza Group AG is a Swiss contract development and manufacturing organization (CDMO) that supports pharmaceutical and biotechnology companies throughout the life cycle of their products. The company provides research, process development, testing, manufacturing, and regulatory support for therapies and other healthcare products, helping customers advance programs from early development through commercial production.
Lonza’s activities include the development and manufacture of biologics, small-molecule medicines, and cell and gene therapies.
Further Reading
- Five stocks we like better than Lonza Group
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
